Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects

This study has been completed.
Sponsor:
Collaborator:
GeneOne Life Science, Inc.
Information provided by:
VGX Pharmaceuticals, LLC
ClinicalTrials.gov Identifier:
NCT00627120
First received: January 17, 2008
Last updated: January 8, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)